share_log

藥明合聯：自願性公告 不尋常價格及交投量變動

WUXI XDC: VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS

Hong Kong Stock Exchange ·  Jan 28 18:45
Summary by Moomoo AI
藥明合聯生物技術有限公司（股份代號：2268）於2024年1月29日發布自願性公告，指出公司股份在香港聯合交易所有限公司的價格及交投量近期出現不尋常變動。公司經合理查詢後確認，目前不知悉導致股價及交易量變動的具體原因，亦無需披露的內幕消息。藥明合聯確認集團業務繼續正常運作，財務狀況無重大變化。公司提醒股東及潛在投資者交易時應保持謹慎。公告由執行董事兼首席執行官李錦才博士代表董事會發出。
藥明合聯生物技術有限公司（股份代號：2268）於2024年1月29日發布自願性公告，指出公司股份在香港聯合交易所有限公司的價格及交投量近期出現不尋常變動。公司經合理查詢後確認，目前不知悉導致股價及交易量變動的具體原因，亦無需披露的內幕消息。藥明合聯確認集團業務繼續正常運作，財務狀況無重大變化。公司提醒股東及潛在投資者交易時應保持謹慎。公告由執行董事兼首席執行官李錦才博士代表董事會發出。
PHARMACEUTICAL UNION BIOTECHNOLOGY CO., LTD. (STOCK CODE: 2268) ISSUED A VOLUNTARY ANNOUNCEMENT ON 29 JANUARY 2024, NOTING UNUSUAL RECENT CHANGES IN THE PRICES AND TRADES OF ITS SHARES ON THE HONG KONG STOCK EXCHANGE LIMITED. AFTER REASONABLE ENQUIRIES, THE COMPANY'S MANAGERS CONFIRMED THAT THE SPECIFIC REASONS FOR THE SHARE PRICE AND TRADING VOLUME CHANGES ARE NOT KNOWN AT THIS TIME AND THAT THERE IS NO NEED TO DISCLOSE INSIDE INFORMATION. Pharmaceutical Joint confirms that the Group's business continues to operate normally and the financial situation has not changed significantly. The Company reminds shareholders and potential investors to exercise caution when trading. The announcement was made by the Executive Director and Chief Executive Officer, Dr. Lee Kam Chai, on behalf of the Board.
PHARMACEUTICAL UNION BIOTECHNOLOGY CO., LTD. (STOCK CODE: 2268) ISSUED A VOLUNTARY ANNOUNCEMENT ON 29 JANUARY 2024, NOTING UNUSUAL RECENT CHANGES IN THE PRICES AND TRADES OF ITS SHARES ON THE HONG KONG STOCK EXCHANGE LIMITED. AFTER REASONABLE ENQUIRIES, THE COMPANY'S MANAGERS CONFIRMED THAT THE SPECIFIC REASONS FOR THE SHARE PRICE AND TRADING VOLUME CHANGES ARE NOT KNOWN AT THIS TIME AND THAT THERE IS NO NEED TO DISCLOSE INSIDE INFORMATION. Pharmaceutical Joint confirms that the Group's business continues to operate normally and the financial situation has not changed significantly. The Company reminds shareholders and potential investors to exercise caution when trading. The announcement was made by the Executive Director and Chief Executive Officer, Dr. Lee Kam Chai, on behalf of the Board.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more